Prospectuses, Presentations and Posters
- Prospectus: Listing of shares - incl. appendices (15.01.26)
- Article in Immunotherapy Advances: Preclinical assessment of MAGE-A4-specific TCR-NK cells against solid tumors (16.12.2025)
- Prospectus: Business Combination Zelluna and Ultimovacs - incl. appendices (28.02.25)
- Presentation og the Business combination of Zelluna and Ultimovacs
Zelluna in the media
- Radium podcast: Episode 344 - Zelluna with Anders Tuv, Chair of the Board in the Company and Managing Director in Radforsk Invest
- Radium podcast: Episode 330 - Zelluna with CEO Namir Hassan
- Beyond BiotechWebcast: TCR-NK: A novel cell therapy transforming cancer treatment
- DNB Webcast: Zelluna with CEO Namir Hassan